Literature DB >> 23736885

Motivators to participation in actual HIV vaccine trials.

Shayesta Dhalla1, Gary Poole.   

Abstract

An examination of actual HIV vaccine trials can contribute to an understanding of motivators for participation in these studies. Analysis of these motivators reveals that they can be categorized as social and personal benefits. Social benefits are generally altruistic, whereas personal benefits are psychological, physical, and financial. In this systematic review, the authors performed a literature search for actual preventive HIV vaccine trials reporting motivators to participation. Of studies conducted in the Organization for Economic Co-operation and Development (OECD) countries, the authors retrieved 12 studies reporting on social benefits and seven reporting on personal benefits. From the non-OECD countries, nine studies reported on social benefits and eight studies on personal benefits. Social benefits were most frequently described on macroscopic, altruistic levels. Personal benefits were most frequently psychological in nature. Rates of participation were compared between the OECD and the non-OECD countries. Knowledge of actual motivators in specific countries and regions can help target recruitment in various types of actual HIV vaccine trials.

Mesh:

Substances:

Year:  2014        PMID: 23736885     DOI: 10.1007/s10461-013-0519-8

Source DB:  PubMed          Journal:  AIDS Behav        ISSN: 1090-7165


  11 in total

1.  Typologies of Altruistic and Financial Motivations for Research Participation.

Authors:  Lisa J Chin; Jacqueline A Berenson; Robert L Klitzman
Journal:  J Empir Res Hum Res Ethics       Date:  2016-10       Impact factor: 1.742

2.  The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants.

Authors:  Jonathan E Volk; Nancy A Hessol; Glenda E Gray; James G Kublin; Gavin J Churchyard; Koleka Mlisana; Maphoshane Nchabeleng; Susan P Buchbinder; Linda-Gail Bekker
Journal:  Int J STD AIDS       Date:  2013-10-08       Impact factor: 1.359

3.  Exceptional Risk: Healthy Volunteers' Perceptions of HIV/AIDS Clinical Trials.

Authors:  Marci D Cottingham; Julianne M Kalbaugh; Teresa Swezey; Jill A Fisher
Journal:  J Acquir Immune Defic Syndr       Date:  2018-10-01       Impact factor: 3.731

4.  Participation in HIV cure-related research: a scoping review of the proxy literature and implications for future research.

Authors:  Karine Dubé; Catalina Ramirez; Jessica Handibode; Jeffrey Taylor; Asheley Skinner; Sandra Greene; Joseph D Tucker
Journal:  J Virus Erad       Date:  2015-10

5.  What risk of death would people take to be cured of HIV and why? A survey of people living with HIV.

Authors:  Benjamin R Murray; Allison Kratka; Karen A Scherr; Nir Eyal; Jennifer Blumenthal-Barby; Kenneth A Freedberg; Daniel R Kuritzkes; James K Hammitt; Regina Edifor; Madelaine N Katz; Kathryn I Pollak; Brian J Zikmund-Fisher; Scott D Halpern; Mary C Barks; Peter A Ubel
Journal:  J Virus Erad       Date:  2019-04-01

Review 6.  Why do patients take part in research? An overview of systematic reviews of psychosocial barriers and facilitators.

Authors:  Rebecca Sheridan; Jacqueline Martin-Kerry; Joanna Hudson; Adwoa Parker; Peter Bower; Peter Knapp
Journal:  Trials       Date:  2020-03-12       Impact factor: 2.279

Review 7.  Altruism: Scoping review of the literature and future directions for HIV cure-related research.

Authors:  Karine Dubé; Kelly E Perry; Kushagra Mathur; Megan Lo; Sogol S Javadi; Hursch Patel; Susanna Concha-Garcia; Jeff Taylor; Andy Kaytes; Lynda Dee; Danielle Campbell; John Kanazawa; David Smith; Sara Gianella; Judith D Auerbach; Parya Saberi; John A Sauceda
Journal:  J Virus Erad       Date:  2020-08-25

8.  An Evaluation of Selected Populations for HIV-1 Vaccine Cohort Development in Nigeria.

Authors:  Ogbonnaya S Njoku; Mark M Manak; Robert J O'Connell; Ashley L W Shutt; Jennifer A Malia; Richard A Heipertz; Sodsai Tovanabutra; Mark J Milazzo; Gideon Akindiran Akintunde; Abraham S Alabi; Aminu Suleiman; Amos A Ogundeji; Terfa S Kene; Robbie Nelson; Ojor R Ayemoba; Darrell E Singer; Merlin L Robb; Sheila A Peel; Nelson L Michael
Journal:  PLoS One       Date:  2016-12-09       Impact factor: 3.240

9.  Volunteer motivators for participating in HIV vaccine clinical trials in Nairobi, Kenya.

Authors:  Borna A Nyaoke; Gaudensia N Mutua; Rose Sajabi; Delvin Nyasani; Marianne W Mureithi; Omu A Anzala
Journal:  PLoS One       Date:  2017-09-07       Impact factor: 3.240

10.  Understanding women's motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence.

Authors:  Ariana W K Katz; Barbara S Mensch; Kubashni Woeber; Petina Musara; Juliane Etima; Ariane van der Straten
Journal:  BMC Womens Health       Date:  2019-01-25       Impact factor: 2.809

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.